Clinical Trial Update: Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD) [Phase 2, Phase 3]

View source ↗

Summary

This update reports results from a Phase 2/3 pediatric trial evaluating the safety, efficacy, and pharmacokinetics of Allegra (fexofenadine) in children with at…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Allegra (fexofenadine)

Snippet

Sponsor: Sanofi | Conditions: Atopic Dermatitis | Phase 2, Phase 3 | Status: COMPLETED